Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
Diabetic Medicine : a Journal of the British Diabetic Association|June 10, 2016
Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based studyR W Thomsen, L M Baggesen, M Søgaard, et al.Diabetes Care|April 14, 2017
Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin InitiatorsElisabeth Svensson, Lisbeth M Baggesen, Søren P Johnsen, et al.Diabetes, Obesity & Metabolism|May 2, 2015
Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort studyR W Thomsen, L M Baggesen, E Svensson, et al.Diabetologia|August 17, 2015
Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetesReimar W Thomsen, Lisbeth M Baggesen, Mette Søgaard, et al.Urology|February 25, 2003
Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cellsG Fechner, F G E Perabo, D H Schmidt, et al.Obesity Science & Practice|September 3, 2020
Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real-world effectiveness study in CanadaSean Wharton, Christiane L Haase, Elham Kamran, et al.Obesity (Silver Spring, Md.)|May 8, 2019
Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in CanadaSean Wharton, Aiden Liu, Arash Pakseresht, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 15, 2016
Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based studyE Svensson, L M Baggesen, R W Thomsen, et al.Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 28, 2018
[Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures]B Jansen-Winkeln, R Thieme, L Haase, et al.Journal of Internal Medicine|March 30, 2011
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levelsC L Haase, R Frikke-Schmidt, B G Nordestgaard, et al.Pageof 17